164 related articles for article (PubMed ID: 6084477)
1. Decreased plasma fibrinolysis in patients with rheumatoid arthritis.
Belch JJ; McArdle B; Madhok R; McLaughlin K; Capell HA; Forbes CD; Sturrock RD
Ann Rheum Dis; 1984 Dec; 43(6):774-7. PubMed ID: 6084477
[TBL] [Abstract][Full Text] [Related]
2. The effect of increasing fibrinolysis in patients with rheumatoid arthritis: a double blind study of stanozolol.
Belch JJ; Madhok R; McArdle B; McLaughlin K; Kluft C; Forbes CD; Sturrock RD
Q J Med; 1986 Jan; 58(225):19-27. PubMed ID: 3517926
[TBL] [Abstract][Full Text] [Related]
3. The fibrinolytic system and its relation to inflammatory diseases.
Clemmensen I; Andersen RB
Semin Arthritis Rheum; 1982 May; 11(4):390-8. PubMed ID: 6179164
[No Abstract] [Full Text] [Related]
4. Effects of oral stanozolol used in the prevention of postoperative deep vein thrombosis on fibrinolytic activity.
Sue-Ling HM; Davies JA; Prentice CR; Verheijen JH; Kluft C
Thromb Haemost; 1985 Feb; 53(1):141-2. PubMed ID: 3873118
[TBL] [Abstract][Full Text] [Related]
5. Prophylactic antithrombotic therapy with stanozolol in patients with familial antithrombin III deficiency.
Winter JH; Fenech A; Bennett B; Douglas AS
Br J Haematol; 1984 Jul; 57(3):527-37. PubMed ID: 6743570
[TBL] [Abstract][Full Text] [Related]
6. Elastase- and plasmin-mediated fibrinolysis in rheumatoid arthritis.
Carmassi F; De Negri F; Morale M; Puccetti R; Chung SI
Int J Tissue React; 1994; 16(2):89-93. PubMed ID: 7960505
[TBL] [Abstract][Full Text] [Related]
7. On fibrinolysis in diabetes mellitus.
Almér LO; Nilsson IM
Acta Med Scand; 1975; 198(1-2):101-6. PubMed ID: 52286
[TBL] [Abstract][Full Text] [Related]
8. Prevention of fibrinolytic shut-down after major surgery by intramuscular stanozolol.
Blamey SL; McArdle BM; Burns P; Lowe GD; Forbes CD; Carter DC; Prentice CR
Thromb Res; 1983 Aug; 31(3):451-9. PubMed ID: 20218001
[TBL] [Abstract][Full Text] [Related]
9. [Activation of the fibrinolytic system with dehydrochlormethyltestosterone].
Hoffmann A; Klöcking HP; Markwardt F
Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):556-62. PubMed ID: 6083926
[TBL] [Abstract][Full Text] [Related]
10. Effects of fish oil on plasma fibrinolysis in patients with mild rheumatoid arthritis.
Lau CS; McLaren M; Belch JJ
Clin Exp Rheumatol; 1995; 13(1):87-90. PubMed ID: 7774110
[TBL] [Abstract][Full Text] [Related]
11. Abnormal plasma fibrinolysis in patients with rheumatoid arthritis and impaired endothelial fibrinolytic response in those complicated by vasculitis.
Lau CS; McLaren M; Hanslip J; Kerr M; Belch JJ
Ann Rheum Dis; 1993 Sep; 52(9):643-9. PubMed ID: 8239758
[TBL] [Abstract][Full Text] [Related]
12. The haemostatic balance in groups of thrombosis-prone patients. With particular reference to fibrinolysis in patients with myocardial infarction.
Gram J
Dan Med Bull; 1990 Jun; 37(3):210-34. PubMed ID: 2192835
[TBL] [Abstract][Full Text] [Related]
13. Fibrinolysis and diabetic retinopathy.
Almér LA; Pandolfi M
Diabetes; 1976; 25(2 SUPPL):807-10. PubMed ID: 61139
[TBL] [Abstract][Full Text] [Related]
14. Increased tissue-type plasminogen activator antigen release is not accompanied by increased systemic fibrinolytic activity in severe neonatal respiratory distress syndrome.
Brus F; Oetomo SB; Schieving J; Groothuis E; Okken A; van Oeveren W
Pediatr Res; 1999 Apr; 45(4 Pt 1):588-94. PubMed ID: 10203153
[TBL] [Abstract][Full Text] [Related]
15. Modulation of rapid plasminogen activator inhibitor in plasma by stanozolol.
Verheijen JH; Rijken DC; Chang GT; Preston FE; Kluft C
Thromb Haemost; 1984 Jul; 51(3):396-7. PubMed ID: 6437007
[TBL] [Abstract][Full Text] [Related]
16. Animal experiments on the enhancement of fibrinolytic potential by anabolic steroids.
Klöcking HP; Markwardt F; Hoffmann A
Biomed Biochim Acta; 1984; 43(4):501-7. PubMed ID: 6548376
[TBL] [Abstract][Full Text] [Related]
17. A double-blind trial of intramuscular stanozolol in the prevention of postoperative deep vein thrombosis following elective abdominal surgery.
Blamey SL; McArdle BM; Burns P; Carter DC; Lowe GD; Forbes CD
Thromb Haemost; 1984 Feb; 51(1):71-4. PubMed ID: 6539002
[TBL] [Abstract][Full Text] [Related]
18. The effect of disease activity related cytokines on the fibrinolytic potential and cICAM-1 expression in rheumatoid arthritis.
Kamper EF; Kopeikina LT; Trontzas P; Potamianou A; Tsiroglou E; Stavridis JC
J Rheumatol; 2000 Nov; 27(11):2545-50. PubMed ID: 11093432
[TBL] [Abstract][Full Text] [Related]
19. Early local and systemic fibrinolytic response to high energy missile trauma.
Almskog B; Risberg B; Teger-Nilsson AC; Seeman T
Acta Chir Scand Suppl; 1982; 508():327-36. PubMed ID: 6177148
[TBL] [Abstract][Full Text] [Related]
20. Depression of tissue-type plasminogen activator and enhancement of urokinase-type plasminogen activator as an expression of local inflammation.
Brommer EJ; Dooijewaard G; Dijkmans BA; Breedveld FC
Thromb Haemost; 1992 Aug; 68(2):180-4. PubMed ID: 1412164
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
